Follow
Gábor Tajti
Gábor Tajti
Verified email at meduniwien.ac.at
Title
Cited by
Cited by
Year
FNDC5/irisin, a molecular target for boosting reward-related learning and motivation
J Zsuga, G Tajti, C Papp, B Juhasz, R Gesztelyi
Medical Hypotheses 90, 23-28, 2016
602016
The voltage-gated potassium channel KV1. 3 as a therapeutic target for venom-derived peptides
G Tajti, DCC Wai, G Panyi, RS Norton
Biochemical pharmacology 181, 114146, 2020
472020
SARS-CoV-2-mRNA booster vaccination reverses non-responsiveness and early antibody waning in immunocompromised patients–a phase four study comparing immune responses in …
A Wagner, E Garner-Spitzer, AM Schötta, M Orola, A Wessely, I Zwazl, ...
Frontiers in immunology 13, 889138, 2022
342022
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
A Hamar, Z Szekanecz, A Pusztai, M Czókolyová, E Végh, Z Pethő, ...
Osteoporosis International, 1-9, 2021
312021
The “proactive” model of learning: Integrative framework for model-free and model-based reinforcement learning utilizing the associative learning-based proactive brain concept.
J Zsuga, K Biro, C Papp, G Tajti, R Gesztelyi
Behavioral Neuroscience 130 (1), 6, 2016
242016
The alteration of Irisin—Brain-derived neurotrophic factor Axis parallels severity of distress disorder in bronchial asthma patients
ME Szilasi, K Pak, L Kardos, VE Varga, I Seres, A Mikaczo, A Fodor, ...
Frontiers in neuroscience 11, 653, 2017
222017
Positive correlation of airway resistance and serum asymmetric dimethylarginine (ADMA) in bronchial asthma patients lacking evidence for systemic inflammation
G Tajti, C Papp, L Kardos, S Keki, K Pak, ME Szilasi, R Gesztelyi, ...
Allergy, Asthma & Clinical Immunology 14, 1-12, 2018
182018
The Kv1.3 K+ channel in the immune system and its “precision pharmacology” using peptide toxins
Z Varga, G Tajti, G Panyi
Biologia futura 72, 75-83, 2021
172021
Positive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammation
G Tajti, R Gesztelyi, K Pak, C Papp, S Keki, ME Szilasi, A Mikaczo, ...
International Journal of Chronic Obstructive Pulmonary Disease, 873-884, 2017
172017
Altered irisin/BDNF axis parallels excessive daytime sleepiness in obstructive sleep apnea patients
CE More, C Papp, S Harsanyi, R Gesztelyi, A Mikaczo, G Tajti, L Kardos, ...
Respiratory Research 20, 1-15, 2019
162019
The voltage-gated proton channel hHv1 is functionally expressed in human chorion-derived mesenchymal stem cells
B Mészáros, F Papp, G Mocsár, E Kókai, K Kovács, G Tajti, G Panyi
Scientific Reports 10 (1), 7100, 2020
152020
Time to kill and time to heal: the multifaceted role of lactoferrin and lactoferricin in host defense
A Ohradanova-Repic, R Praženicová, L Gebetsberger, T Moskalets, ...
Pharmaceutics 15 (4), 1056, 2023
142023
Periodic Membrane Potential and Ca2+ Oscillations in T Cells Forming an Immune Synapse
F Papp, P Hajdu, G Tajti, A Toth, E Nagy, Z Fazekas, S Kovacs, G Vámosi, ...
International Journal of Molecular Sciences 21 (5), 1568, 2020
142020
‘Proactive’use of cue-context congruence for building reinforcement learning’s reward function
J Zsuga, K Biro, G Tajti, ME Szilasi, C Papp, B Juhasz, R Gesztelyi
BMC neuroscience 17, 1-11, 2016
132016
Optimization of Pichia pastoris expression system for high-level production of margatoxin
MU Naseem, G Tajti, A Gaspar, TG Szanto, J Borrego, G Panyi
Frontiers in pharmacology 12, 733610, 2021
92021
Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin
A Ohradanova-Repic, R Skrabana, L Gebetsberger, G Tajti, P Baráth, ...
Frontiers in immunology 13, 958581, 2022
82022
Immunomagnetic separation is a suitable method for electrophysiology and ion channel pharmacology studies on T cells
G Tajti, TG Szanto, A Csoti, G Racz, C Evaristo, P Hajdu, G Panyi
Channels 15 (1), 53-66, 2021
82021
sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1. 3 channels of human T cells with improved selectivity
A Csoti, RCN Meza, F Bogár, G Tajti, TG Szanto, Z Varga, GB Gurrola, ...
Biochemical Pharmacology 199, 115023, 2022
72022
Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.
A Wagner, A Ohradanova-Repic, L Gebetsberger, G Tajti, M Kundi, ...
Immunology Letters 250, 1-6, 2022
42022
Effects of one-year tofacitinib therapy on lipids and adipokines in association with vascular pathophysiology in rheumatoid arthritis
M Czókolyová, A Hamar, A Pusztai, G Tajti, E Végh, Z Pethő, N Bodnár, ...
Biomolecules 12 (10), 1483, 2022
32022
The system can't perform the operation now. Try again later.
Articles 1–20